Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (atsiveria naujas langas)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

Šaltinis‎: Hemoglobin 2014;38(1):44-8.

Kodas‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (atsiveria naujas langas)

Hydroxyurea in thalassemia intermedia--a promising therapy. (atsiveria naujas langas)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Šaltinis‎: Ann Hematol 2005;84(7):441-6.

Kodas‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (atsiveria naujas langas)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (atsiveria naujas langas)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

Šaltinis‎: J Clin Pathol 2010;63(2):147-50.

Kodas‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (atsiveria naujas langas)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (atsiveria naujas langas)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

Šaltinis‎: Eur J Haematol 2009;82(3):213-8.

Kodas‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (atsiveria naujas langas)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (atsiveria naujas langas)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

Šaltinis‎: Eur J Haematol 2010;84(1):52-8.

Kodas‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (atsiveria naujas langas)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (atsiveria naujas langas)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

Šaltinis‎: Blood Cells Mol Dis 2000;26(5):453-66.

Kodas‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (atsiveria naujas langas)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (atsiveria naujas langas)

Perrine SP.

Šaltinis‎: Pediatr Ann 2008;37(5):339-46.

Kodas‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (atsiveria naujas langas)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (atsiveria naujas langas)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Šaltinis‎: Ann N Y Acad Sci 2005;1054:250-6.

Kodas‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (atsiveria naujas langas)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (atsiveria naujas langas)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Šaltinis‎: Acta Haematol 2004;111(4):189-95.

Kodas‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (atsiveria naujas langas)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (atsiveria naujas langas)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

Šaltinis‎: Blood Purif 2004;22(5):453-60.

Kodas‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (atsiveria naujas langas)

The role of recombinant human erythropoietin in the treatment of thalassemia. (atsiveria naujas langas)

Rachmilewitz EA, Aker M.

Šaltinis‎: Ann N Y Acad Sci 1998;850:129-38.

Kodas‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (atsiveria naujas langas)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (atsiveria naujas langas)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

Šaltinis‎: Br J Haematol 2011;154(2):281-4.

Kodas‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (atsiveria naujas langas)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (atsiveria naujas langas)

Thein SL.

Šaltinis‎: Blood Rev 2012;26 Suppl 1:S35-9.

Kodas‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (atsiveria naujas langas)